Chief Operating Officer
Pearl Pathways, part of Versiti Clinical Trial Services
Kimberley Buytaert-Hoefen, Ph.D. is the Chief Operating Officer at Versiti Clinical Trial Services, Pearl Pathways. With extensive experience in regulatory affairs and clinical trial strategy, Dr. Buytaert-Hoefen specializes in precision medicine and advanced therapies. She has a proven track record of navigating complex regulatory environments across multiple regions, ensuring compliance and successful product approvals.
Sponsored Presentation: Global regulatory strategy for precision medicine
Wednesday, October 8, 2025
4:00 PM - 4:25 PM EST